Search - tctmd.com

Displaying 81 - 100 of 108

Sort: Relevancy | Date

Presentation ECHO 2016

The Evaluation of Chest Pain: Coronary Artery and Aortic Disease Algorithms for Use of Multimodality Imaging

Presenter: Mario J. Garcia

March 21, 2016

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

Presentation TCT 2015

Featured Lecture: First Report of the 5-Year Cohort B Multimodality Imaging Results (And My Clinical Predictions Based on These Findings)

Presenter: Stephen G. Ellis, Patrick W. Serruys

October 14, 2015

Presentation ECHO 2015

Can Echo Stand Alone? The Value of Multimodality Imaging

Presenter: Mario J Garcia

April 26, 2015

Presentation TCT 2014

Multimodality intravascular imaging assessment of plaque erosion vs plaque rupture in patients with acute coronary syndrome

Presenter: Sang Wook Kim

September 16, 2014

Presentation TCT 2014

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos

September 14, 2014

Presentation TCT 2013

Next Generation Multimodality Imaging Systems: Added Value vs. Cost and Complexity?

Presenter: Susheel Kodali

October 31, 2013

Presentation TCT 2013

Multimodality Imaging Requirements in the Screening Evaluation of TAVR Candidates

Presenter: Lutz Buellesfeld

October 31, 2013

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

Presenter: 53632|Koen Nieman

August 07, 2013

Presentation

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Gregg W. Stone

July 10, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

Presentation EuroPCR 2013

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Alexandre Abizaid

May 21, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

Presentation Cell Therapy 2013

Multimodality Imaging: Enhancing Outcomes with Available Technology

Presenter: Amish Raval

January 22, 2013

News Daily News

European Registries Show Solid Gains in TAVR Outcomes

Caitlin E. Cox

January 13, 2013

Presentation TCT 2012

Role of Multimodality Imaging in the Evaluation of Aortic Valve Disease

Presenter: Maurice Sarano

October 24, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

News Daily News

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Caitlin E. Cox

July 30, 2012

Advertisement

The Evaluation of Chest Pain: Coronary Artery and Aortic Disease Algorithms for Use of Multimodality Imaging

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Featured Lecture: First Report of the 5-Year Cohort B Multimodality Imaging Results (And My Clinical Predictions Based on These Findings)

Can Echo Stand Alone? The Value of Multimodality Imaging

Multimodality intravascular imaging assessment of plaque erosion vs plaque rupture in patients with acute coronary syndrome

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Next Generation Multimodality Imaging Systems: Added Value vs. Cost and Complexity?

Multimodality Imaging Requirements in the Screening Evaluation of TAVR Candidates

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

Multimodality Imaging: Enhancing Outcomes with Available Technology

European Registries Show Solid Gains in TAVR Outcomes

Role of Multimodality Imaging in the Evaluation of Aortic Valve Disease

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content